Covalon Technologies, a developer of advanced tissue repair applications, has entered into an agreement with a Canadian distributor to distribute its ColActive Plus Ag collagen wound care dressings through out the Middle East.
The agreement includes a purchase commitments of $700,000 in the first year and a total minimum purchase commitment of $11.2m over five years.
The ColActive Plus Ag is a denatured collagen-based matrix which allows the material to deliver antimicrobial silver ions to the sites of various trauma including burns and wounds.
Covalon CEO Brian Pedlar said their partner has demonstrated that they have a healthcare relationships in a number of Middle Eastern countries, and they look forward to expand new relationship through the distribution of additional medical products.
"This has allowed Covalon to start to market its existing advanced wound care products as well as introduce both new formulations and totally new technologies," Pedlar said.